OptimizeRx Corp — Director's Dealing 2025

Nov 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2025-08-21

Reporting Person: Merrell Brendan W. (CHIEF OPERATING OFFICER)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-21	Common Stock	A	10417	—	Acquired	27691	Direct
2025-10-03	Common Stock	F	483	$18.75	Disposed	27208	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-21	Stock Option	$16.14	A	23437	Acquired	2030-08-21	Common Stock (23437)	Direct

Footnotes

F1: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on
August 21, 2026, which is the first anniversary of the grant date.

F2: These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

F3: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.